Chart - NTI, page-18

It may have been when you posted at 4.8c… very easy for me to say that in hindsight. I feel that a 5-6c trading range is on the cards for a while, so some opportunity to trade the 20% range until we get some news. I have bought a couple of the listed options recently for. I feel anything sub 1c with nearly 2 years duration is good value IMHO.. DYOR if you don’t understand options risk, not going to explain for those that don’t understand. Cap raise is the issue for the options… but, nice to have a bit of blue sky exposure if they get a fast track from FDA or some timely trial results, or announce a partner ( I haven’t discussed this a lot, but could solve all and any cap raise risk, mgmt just hasn’t ever mentioned it as a plan to fund - but it should be implied in all Biotec). I trimmed off my heads to fund the oppies so no net change in $, but about triple the exposure Works for me, I can bottom drawer now as not many $$ invested. GLTAH.